Influenza A Nucleoprotein (NP) protein (H3N2 strain)Â
Catalog Number:
G17H33
Description:
Influenza (Flu) Nucleocapsid protein or nucleoprotein (NP) is the most abundant viral protein in infected cells, therefore the NP has been used for anti‑flu drug development or flu diagnosis. A recombinant Influenza A NP from H3N2 strain (A/Darwin/9/2021)/(A/Darwin/6/2021) was produced by insect cells, followed by purification. This product contains N-terminal Myc tag and C-terminal human Fc tag followed by a 6 hexa-histidine tag. Amino acid sequence is available upon request. This product has been run on SDS-PAGE with reduced condition, where the target protein with a calculated MW of ~85 kDa (including tags) was shown. We evaluated its binding to His tag-specific antibody (Cat.No. J96C86) and Myc tag-specific antibody (Cat.No. M52T82) in ELISAs, see results.
Applications:
Crystallization (Crys), ELISA, SDS-PAGE (SDS), Western Blotting (WB), Immunization or Antibody Sorting Probe, and others
Source:
Insect cells
Biosafety Level:
BSL-1
Organism:
Influenza A
Size and Formulation:
100 or 500 μg in PBS, pH7.2, without preservatives.
Note: Not lyophilized formulation, so no lyophilized protectant reagents added.
Endotoxin:
Less than 1.0 EU per μg by the LAL method / rFC method.
Shipping or storage condition
Ship with dry ice. Recommend -80°C storage for long-term. Store at 4°C or −20 °C for short-term.  Multiple freeze/Thaw cycles will reduce its activity. Aliquot is recommended.
Note:
For research use only.













